GLOW Blend: research overview

Stack: GHK-Cu (70 mg) + BPC-157 (10 mg) + TB-500 analog (10 mg). Combined tissue-repair research compound.

Healing. Molecular weight 340 Da (main component); half-life —. Reference material compiled from the published literature. For laboratory research only; nothing on this page is medical advice or a claim about a product.

How it is studied

A multi-peptide blend combining GHK-Cu (70 mg) for ECM remodeling and copper-mediated antioxidant gene expression, BPC-157 (10 mg) for proposed angiogenesis-modulating tissue-repair signaling, and TB-500 analog (10 mg) for actin-sequestration and cell-migration activity. In research literature, these components are individually studied and their combined behavior is an active research interest in systemic tissue-repair models.

GLOW Blend is a commercial formulation combining three peptides studied independently for tissue-repair pathways. The listed molecular weight reflects the GHK-Cu component only and is used as a sort key — a single MW is not meaningful for a multi-peptide blend. Reconstitution and dose calculations should be performed per-component using each peptide's mass within the blend (the calculator on this site can be re-run for each component).

Half-life, with its caveats

Variable across the three components — characterize each independently: GHK-Cu ~30–60 min (rat, SC), BPC-157 ~15 min (rat, IV), TB-500/Tβ4 ~1.5–3 h (human IV; dose-dependent).

How to read this page

Mechanism describes what the published studies tested, not what a product does.
Reported research areas list where the compound has been studied. They are not indications.
Dose ranges are what the literature reports, quoted for reference. They are not dosing advice.
Co-factor studies carry PubMed citations; open the source before relying on a figure.

Co-factors

Compounds studied alongside it

Sparse literature

Compounds identified in published research as sharing pathways with GLOW Blend, or studied alongside it in trials. Reference material only — not a recommendation, not medical advice. Citations link to PubMed.

No direct literature

GLOW Blend is a multi-peptide formulation combining GHK-Cu, BPC-157, and TB-500. No published PubMed literature studies this exact blend or characterises cofactors specific to the combination. Co-factor data for this blend should follow the component peptides — see the ghk-cu, bpc-157, and tb-500 entries in this report. The cross-cutting cofactors that appear in multiple component entries (ascorbate for the collagen hydroxylation step, zinc as a permissive cofactor for MMP-mediated matrix remodelling, and the copper-zinc balance caution from the GHK-Cu entry) are the most defensible carry-overs for any GLOW-Blend protocol-design discussion.

All reading